Top Markets
#1 Official Trump Official Trump +37.23%
#2 Siacoin Siacoin +22.82%
#3 Melania Meme Melania Meme +20.04%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +19.89%
#5 Pump.fun Pump.fun +19.64%
#6 Unit Pump Unit Pump +19.64%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +18.56%
#9 Wrapped POL Wrapped POL +17.44%
#10 Mubarak Mubarak +17.31%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Rank in Stocks #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Share Price
$20.65
Last synced: 2023-03-01
Market Cap
$82.52M
Change (1 day)
-0.58%
Change (1 year)
0.00%
Country
US
Trade Opiant Pharmaceuticals, Inc. (OPNT)

Category

Healthcare
P/B ratio for Opiant Pharmaceuticals, Inc. (OPNT)
P/B ratio as of 2026 TTM: 0
According to Opiant Pharmaceuticals, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Opiant Pharmaceuticals, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH